Boston, MA · Founded 2021 · Privately Held (backing)
Developer of a therapeutic discovery platform designed to identify compounds for treating brain and mental health conditions. Sensorium Therapeutics is based in Boston, MA and was founded in 2021. Its last reported valuation was $47 million in Sep 2022. It has raised $69.7 million across 3 recorded rounds; the latest was a $26.8 million early-stage round in Jan 2025.
Last reported valuation
$47.0M
Oct 2026
Priced at
—
Total raised
$69.7M
Last round
Early Stage VC
Jan 2025
Team — not yet on record
No current team members for Sensorium Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Sensorium Therapeutics with a free account
·The complete investor list: 16 names
·Watch Sensorium Therapeutics: the Monday email on marks, rounds and moves
